Valeant’s new CFO gets huge pay bump

Laval, Quebec, Canada-based Valeant Pharmaceuticals’ new CFO Paul S. Herendeen will receive a base salary of $1 million and is eligible for an additional bonus as high as $2.4 million, according to The Wall Street Journal.

Advertisement

 

Mr. Herendeen joined Valeant from Florham Park, N.J.-based Zoetis, a global animal health company. Under his deal with Valeant, Mr. Herendeen will also get $10 million in cash to compensate him for equity compensation he gave up when he left Zoetis, according to the report.

In 2015, Mr. Herendeen’s pay totaled $630,000 as executive vice president and CFO of Zoetis. He also received a $595,350 bonus last year. 

More articles on executive compensation:

Mylan execs took large raises amidst EpiPen price spikes
Rate of Mass. hospital executive pay growth eclipses healthcare spending
How did compensation change for executives, providers from 2015 to 2016?

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Compensation Issues

Advertisement

Comments are closed.